Novel Agents for Graft-Versus-Host Disease (GVHD) (Advances in the Management of Oncology, Stem Cell- and Solid Organ-Transplant Patients)

Acute and chronic GVHD are potentially lethal complications after stem cell transplantation. Steroids are the appropriate first-line treatment for both. However, if patients do not adequately benefit from steroid therapy, mortality is high. This presentation will review treatment strategies for patients suffering from acute or chronic steroid-refractory GVHD while maintaining the graft-versus-tumor effect to avoid a potential rise in relapse-related mortality.

Learning Objectives
At the end of this educational activity, participants should be able to

  1. Discuss treatment strategies for patients suffering from acute or chronic steroid-refractory GVHD while maintaining the graft-versus-tumor effect to avoid a potential rise in relapse-related mortality

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

  • Completing the entire activity
  • Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged in to your account to participate in this activity. Start by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.

Method for Calculating CE Credit
CE credit was calculated by the complexity of content.

Faculty Listing
John Koreth, MD, PhD
Assistant Professor of Medicine
Harvard Medical School;
Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Boston, Massachusets

Disclosures
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.

Financial Relationship Key
A-Advisory Board
C-Consultant
E-Employee
G- Grant/Research Support
I-Stocks and Other Ownership Interests
S-Speakers’ Bureau
O-Other Financial or Material Support
N-Nothing to disclose


Resolution Key
R1-Restricted to Best Available Evidence
R2-Removed/Altered Financial Relationship
R3-Refrain from Recommending Products or Services
R4-Peer Review of Presentation
R5-Ensure that content is independent of commercial bias
R6-Recommend an alternative speaker for this topic for the planning committee’s consideration
N/A-Not Applicable

 

Last Name

First Name

Disclosure

Resolution

Role

Chart-Hart

Sarah

UnitedHealth Group (E) (I)

N/A

Planner

Gleason

Rebecca

UnitedHealth Group (E) (I)

N/A

Planner

Lindberg

Barbara

UnitedHealth Group (E) (I)

N/A

Planner

AbecassisMichaelNN/APlanner

Bishop

Michael

Celgene (S), Novartis (C)

R1

Planner

Koreth

John

Millennium Pharmaceuticals,
Prometheus Labs Inc.,
Otsuka Pharmaceuticals (G)

R1

Speaker

Provided By
This activity is provided by OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.

Target Audience

This activity is designed to meet the educational needs of physicians, nurses, case managers, and other healthcare professionals.

Activity summary
Available credit: 
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
Activity opens: 
10/31/2013
Activity expires: 
10/31/2015
Rating: 
0

Available Credit

  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
Please log in to register.